Recombinant Human SCGB3A2 protein is a Human Full Length protein, in the 22 to 93 aa range, expressed in Escherichia coli, with >95% purity, < 1 EU/µg endotoxin level and suitable for SDS-PAGE, HPLC.
F L I N K V P L P V D K L A P L P L D N I L P F M D P L K L L L K T L G I S V E H L V E G L R K C V N E L G P E A S E A V K K L L E A L S H L V
| Application | Reactivity | Dilution info | Notes |
|---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application HPLC | Reactivity Reacts | Dilution info - | Notes - |
Select an associated product type
Secreted cytokine-like protein (PubMed:12847263). Binds to the scavenger receptor MARCO (PubMed:12847263). Can also bind to pathogens including the Gram-positive bacterium L.monocytogenes, the Gram-negative bacterium P.aeruginosa, and yeast (PubMed:12847263). Strongly inhibits phospholipase A2 (PLA2G1B) activity (PubMed:24213919). Seems to have anti-inflammatory effects in respiratory epithelium (By similarity). Also has anti-fibrotic activity in lung (PubMed:24213919). May play a role in fetal lung development and maturation (PubMed:24213919). Promotes branching morphogenesis during early stages of lung development (PubMed:24213919). In the pituitary, may inhibit production of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) (By similarity).
PNSP1, UGRP1, UNQ566/PRO1128, SCGB3A2, Secretoglobin family 3A member 2, Pneumo secretory protein 1, Uteroglobin-related protein 1, PnSP-1
Recombinant Human SCGB3A2 protein is a Human Full Length protein, in the 22 to 93 aa range, expressed in Escherichia coli, with >95% purity, < 1 EU/µg endotoxin level and suitable for SDS-PAGE, HPLC.
pH: 7.4
Constituents: 99% Phosphate Buffer, 0.88% Sodium chloride
Greater than 95% as determined by SEC-HPLC and reducing SDS-PAGE
Secreted cytokine-like protein (PubMed:12847263). Binds to the scavenger receptor MARCO (PubMed:12847263). Can also bind to pathogens including the Gram-positive bacterium L.monocytogenes, the Gram-negative bacterium P.aeruginosa, and yeast (PubMed:12847263). Strongly inhibits phospholipase A2 (PLA2G1B) activity (PubMed:24213919). Seems to have anti-inflammatory effects in respiratory epithelium (By similarity). Also has anti-fibrotic activity in lung (PubMed:24213919). May play a role in fetal lung development and maturation (PubMed:24213919). Promotes branching morphogenesis during early stages of lung development (PubMed:24213919). In the pituitary, may inhibit production of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) (By similarity).
Belongs to the secretoglobin family. UGRP subfamily.
SCGB3A2 also recognized as uteroglobin-related protein 1 (UGRP1) is a small secreted protein with a molecular mass around 10 kDa. It is mainly expressed in the epithelial cells of the respiratory tract notably the lungs where it plays a role in modulating immune responses. In terms of structure SCGB3A2 shares similarities with other secretoglobin family members indicating conserved functional motifs. Its expression is tightly regulated and reflects its involvement in maintaining respiratory health.
SCGB3A2 acts as an anti-inflammatory agent that modulates immune cell activity and cytokine signaling within the lungs. It does not form known protein complexes but interacts with other immune mediators to reduce inflammation. Furthermore SCGB3A2 has roles in cell proliferation and repair mechanisms especially in response to lung injury. Its interaction with various cytokines supports tissue regeneration and homeostasis making it important in maintaining lung function.
SCGB3A2 interacts in immune regulatory pathways significant in lung tissue. Notably it participates in pathways related to the suppression of inflammatory cytokine production and has a working relationship with proteins such as IL-10 and TGF-beta that mitigate excessive immune reactions. These interactions exhibit roles in the regulation of immune responses and the promotion of tissue repair making SCGB3A2 part of important biological processes that protect lung integrity.
SCGB3A2 is linked to conditions such as asthma and chronic obstructive pulmonary disease (COPD) where inflammation plays an important role. Alterations in SCGB3A2 expression correlate with disease severity suggesting its potential as a biomarker. Its relationship with TGF-beta is of particular interest as dysregulation of this protein contributes to fibrotic changes in lung tissue. Studies continue to explore how modulating SCGB3A2 levels may influence disease progression and treatment outcomes in inflammatory lung disorders.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com